AngioDynamics Stock News

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AngioDynamics (ANGO –

AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc KeyBanc ANGO

Goldman Sachs Group Inc. increased its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO) by 50.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securiti

ANGO earnings call for the period ending March 31, 2020.

Q3 2020 AngioDynamics Inc Earnings Call

AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2020 Results Earnings Conference Call April 7, 2020 8:00 AM ET Company Participants Jim Clemmer - President & CEO Steve

Shares of AngioDynamics (NASDAQ:ANGO) jumped over 7% after the company reported upbeat Q3 results.Quarterly Results Earnings per share fell 94.74% year over year to $0.01, which beat the estimate of (

Fly Intel: Pre-market Movers XOM M W HOLX NGM GBX ANGO LNN SEAC

AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc KeyBanc ANGO

AngioDynamics (ANGO) delivered earnings and revenue surprises of 133.33% and 1.98%, respectively, for the quarter ended February 2020. Do the numbers hold clues to what lies ahead for the stock?

AngioDynamics (ANGO) delivered earnings and revenue surprises of 133.33% and 1.98%, respectively, for the quarter ended February 2020. Do the numbers hold clues to what lies ahead for the stock?

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 6.) * Forty Seven Inc (NASDAQ: FTSV) * Masimo Corporat

AngioDynamics withdraws FY20 guidance due to COVID-19 ANGO

AngioDynamics reports Q3 adj. EPS 1c, consensus (3c) ANGO